Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials
出版年份 2015 全文链接
标题
Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials
作者
关键词
Young age, pCR, Neoadjuvant, Breast cancer, Survival, Chemotherapy, Outcome
出版物
BREAST CANCER RESEARCH AND TREATMENT
Volume 152, Issue 2, Pages 377-387
出版商
Springer Nature
发表日期
2015-06-24
DOI
10.1007/s10549-015-3479-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
- (2015) Prudence A. Francis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
- (2014) Patricia Cortazar et al. LANCET
- The prognostic impact of age in patients with triple-negative breast cancer
- (2013) Cornelia Liedtke et al. BREAST CANCER RESEARCH AND TREATMENT
- Epidemiology of Breast Cancer - Current Figures and Trends
- (2013) N. Eisemann et al. GEBURTSHILFE UND FRAUENHEILKUNDE
- Effect of Age on Breast Cancer Outcomes in Women With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Results From a Herceptin Adjuvant Trial
- (2013) Ann H. Partridge et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast Cancer in Young Women a Clinical Challenge to Be Addressed in a Multidisciplinary Setting
- (2012) Fatima Cardoso et al. Breast Care
- Elucidating Prognosis and Biology of Breast Cancer Arising in Young Women Using Gene Expression Profiling
- (2012) Hatem A. Azim et al. CLINICAL CANCER RESEARCH
- The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer
- (2012) Fatima Cardoso et al. EUROPEAN JOURNAL OF CANCER
- Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
- (2012) Gunter von Minckwitz et al. JOURNAL OF CLINICAL ONCOLOGY
- Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial
- (2012) Michael Untch et al. LANCET ONCOLOGY
- Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
- (2012) Gunter von Minckwitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin–cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer—outcome on prognosis
- (2011) M. Untch et al. ANNALS OF ONCOLOGY
- PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer—results at the time of surgery
- (2011) M. Untch et al. ANNALS OF ONCOLOGY
- Breast cancer statistics, 2011
- (2011) Carol DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Age, Breast Cancer Subtype Approximation, and Local Recurrence After Breast-Conserving Therapy
- (2011) Nils D. Arvold et al. JOURNAL OF CLINICAL ONCOLOGY
- Pathologic Complete Response After Neoadjuvant Chemotherapy Plus Trastuzumab Predicts Favorable Survival in Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: Results From the TECHNO Trial of the AGO and GBG Study Groups
- (2011) Michael Untch et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of neoadjuvant anthracycline–taxane-based chemotherapy in different biological breast cancer phenotypes: overall results from the GeparTrio study
- (2010) Jens Huober et al. BREAST CANCER RESEARCH AND TREATMENT
- Impact of treatment characteristics on response of different breast cancer phenotypes: pooled analysis of the German neo-adjuvant chemotherapy trials
- (2010) Gunter von Minckwitz et al. BREAST CANCER RESEARCH AND TREATMENT
- Neoadjuvant Treatment With Trastuzumab in HER2-Positive Breast Cancer: Results From the GeparQuattro Study
- (2010) Michael Untch et al. JOURNAL OF CLINICAL ONCOLOGY
- Intensive Dose-Dense Compared With Conventionally Scheduled Preoperative Chemotherapy for High-Risk Primary Breast Cancer
- (2009) Michael Untch et al. JOURNAL OF CLINICAL ONCOLOGY
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
- (2009) Michael Gnant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
- (2009) Hanna Fredholm et al. PLoS One
- Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
- (2008) Carey K. Anders et al. JOURNAL OF CLINICAL ONCOLOGY
- Intensified Neoadjuvant Chemotherapy in Early-Responding Breast Cancer: Phase III Randomized GeparTrio Study
- (2008) G. von Minckwitz et al. JNCI-Journal of the National Cancer Institute
- Neoadjuvant Vinorelbine-Capecitabine Versus Docetaxel-Doxorubicin-Cyclophosphamide in Early Nonresponsive Breast Cancer: Phase III Randomized GeparTrio Trial
- (2008) G. von Minckwitz et al. JNCI-Journal of the National Cancer Institute
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More